Agile Thrpe
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.2711
- Today's High:
- $0.2900
- Open Price:
- $0.2800
- 52W Low:
- $0.25
- 52W High:
- $32.8
- Prev. Close:
- $0.2789
- Volume:
- 505998
Company Statistics
- Market Cap.:
- $0.011 billion
- Book Value:
- 0.277
- Revenue TTM:
- $0.007 billion
- Operating Margin TTM:
- -974%
- Gross Profit TTM:
- $-0.007 billion
- Gross Profit TTM:
- $-0.007 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- -95.6%
- Return on Equity TTM:
- -457.5%
Company Profile
Agile Thrpe had its IPO on 2014-05-23 under the ticker symbol AGRX.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Agile Thrpe has a staff strength of 0 employees.
Stock update
Shares of Agile Thrpe opened at $0.28 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $0.27 - $0.29, and closed at $0.28.
This is a +0.39% increase from the previous day's closing price.
A total volume of 505,998 shares were traded at the close of the day’s session.
In the last one week, shares of Agile Thrpe have increased by 0%.
Agile Thrpe's Key Ratios
Agile Thrpe has a market cap of $0.011 billion, indicating a price to book ratio of 3.071 and a price to sales ratio of 1.634.
In the last 12-months Agile Thrpe’s revenue was $0.007 billion with a gross profit of $-0.007 billion and an EBITDA of $-0.063 billion. The EBITDA ratio measures Agile Thrpe's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Agile Thrpe’s operating margin was -974% while its return on assets stood at -95.6% with a return of equity of -457.5%.
In Q2, Agile Thrpe’s quarterly earnings growth was a positive 0% while revenue growth was a positive 79.4%.
Agile Thrpe’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-26.16 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Agile Thrpe’s profitability.
Agile Thrpe stock is trading at a EV to sales ratio of 1.641 and a EV to EBITDA ratio of -0.175. Its price to sales ratio in the trailing 12-months stood at 1.634.
Agile Thrpe stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Agile Thrpe ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Agile Thrpe ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Agile Thrpe’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Agile Thrpe's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Agile Thrpe paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $0.28
- 52-Week High
- $32.8
- 52-Week Low
- $0.25
- Analyst Target Price
- $3
Agile Thrpe stock is currently trading at $0.28 per share. It touched a 52-week high of $32.8 and a 52-week low of $32.8. Analysts tracking the stock have a 12-month average target price of $3.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Agile Thrpe
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Agile Therapeutics, Inc., a women’s healthcare company, researches, develops, and markets prescription contraceptive products for women in the United States. The company is headquartered in Princeton, New Jersey.